<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36446465</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Prevalence, pathophysiology, prediction and health-related quality of life of long COVID: study protocol of the longitudinal multiple cohort CORona Follow Up (CORFU) study.</ArticleTitle><Pagination><StartPage>e065142</StartPage><MedlinePgn>e065142</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e065142</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-065142</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The variety, time patterns and long-term prognosis of persistent COVID-19 symptoms (long COVID-19) in patients who suffered from mild to severe acute COVID-19 are incompletely understood. Cohort studies will be combined to describe the prevalence of long COVID-19 symptoms, and to explore the pathophysiological mechanisms and impact on health-related quality of life. A prediction model for long COVID-19 will be developed and internally validated to guide care in future patients.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">Data from seven COVID-19 cohorts will be aggregated in the longitudinal multiple cohort CORona Follow Up (CORFU) study. CORFU includes Dutch patients who suffered from COVID-19 at home, were hospitalised without or with intensive care unit treatment, needed inpatient or outpatient rehabilitation and controls who did not suffer from COVID-19. Individual cohort study designs were aligned and follow-up has been synchronised. Cohort participants will be followed up for a maximum of 24 months after acute infection. Next to the clinical characteristics measured in individual cohorts, the CORFU questionnaire on long COVID-19 outcomes and determinants will be administered digitally at 3, 6, 12, 18 and 24 months after the infection. The primary outcome is the prevalence of long COVID-19 symptoms up to 2&#x2009;years after acute infection. Secondary outcomes are health-related quality of life (eg, EQ-5D), physical functioning, and the prevalence of thromboembolic complications, respiratory complications, cardiovascular diseases and endothelial dysfunction. A prediction model and a patient platform prototype will be developed.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Approval was obtained from the medical research ethics committee of Maastricht University Medical Center+ and Maastricht University (METC 2021-2990) and local committees of the participating cohorts. The project is supported by ZonMW and EuroQol Research Foundation. Results will be published in open access peer-reviewed scientific journals and presented at (inter)national conferences.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT05240742.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghossein-Doha</LastName><ForeName>Chahinda</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wintjens</LastName><ForeName>Marieke S J N</ForeName><Initials>MSJN</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Medicine, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssen</LastName><ForeName>Emma B N J</ForeName><Initials>EBNJ</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Dorthe</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0182-9569</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heemskerk</LastName><ForeName>Stella C M</ForeName><Initials>SCM</Initials><Identifier Source="ORCID">0000-0002-1320-8084</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselbergs</LastName><ForeName>Folkert W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, Faculty of Population Health Sciences, Health Data Research UK and Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birnie</LastName><ForeName>Erwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Scientific Department, EuroQol Research Foundation, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonsel</LastName><ForeName>Gouke J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Scientific Department, EuroQol Research Foundation, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bussel</LastName><ForeName>Bas C T</ForeName><Initials>BCT</Initials><Identifier Source="ORCID">0000-0003-1621-7848</Identifier><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cals</LastName><ForeName>Jochen W L</ForeName><Initials>JWL</Initials><Identifier Source="ORCID">0000-0001-9550-5674</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ten Cate</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Department of Internal Medicine, Thrombosis Expert Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haagsma</LastName><ForeName>Juanita</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmen</LastName><ForeName>Bena</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Care and Public Health Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Functioning, Participation &amp; Rehabilitation, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Horst</LastName><ForeName>Iwan C C</ForeName><Initials>ICC</Initials><Identifier Source="ORCID">0000-0003-3891-8522</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kietselaer</LastName><ForeName>Bastiaan L J H</ForeName><Initials>BLJH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Kruif</LastName><ForeName>Martijn D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linschoten</LastName><ForeName>Marijke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Netherlands Heart Institute, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Santen</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernooy</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Maastricht UMC+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willems</LastName><ForeName>Loes H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboudumc Radboud Institute for Health Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westerborg</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warle</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Radboudumc Radboud Institute for Health Sciences, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Kuijk</LastName><ForeName>Sander M J</ForeName><Initials>SMJ</Initials><Identifier Source="ORCID">0000-0003-2796-729X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht UMC+, Maastricht, The Netherlands sander.van.kuijk@mumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05240742</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000068397">Clinical Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EPIDEMIOLOGY</Keyword><Keyword MajorTopicYN="N">Protocols &amp; guidelines</Keyword><Keyword MajorTopicYN="N">Public health</Keyword></KeywordList><CoiStatement>Competing interests: BCTvB, BH, BLJHK, JH, DK, EB, EBNJJ, GJB, ICCvdH, JH, JWLC, LHW, MSJNW, MW, RW, SCMH, SMJK, SvS and BH declare no competing interests. FAK received research support from Bayer, BMS, Boehringer-Ingelheim, MSD, Daiichi-Sankyo, Actelion, Boston Scientific, The Netherlands Organization for Health Research and Development (ZonMW), The Dutch Thrombosis Association, and The Dutch Heart Foundation. FWA is supported by the National Institute of Health Research University College London Hospitals Biomedical Research Centre. For the CAPACITY-COVID cohort participating in CORFU, FWA and ML received support from Dutch Heart Foundation (2020B006 CAPACITY) an The Netherlands Organization for Health Research and Development (ZonMW) (grant number 10430102110006 DEFENCE). HTC received support from Bayer, received consulting fees from Pfizer, Leo, Alveron, Viatris, Astra Zeneca, and Galapagos, and has stock (options) in Coagulation Profile. KV has royalities or licences for Philips, Medtronic, Abbott, and Biosense Webster, received consulting fees from Philips, Biosense Webster, Boston Scientific, and Medtronic, and has a role in the European Heart Rhythm Association congress organization and digital committee. MDdK received a presentation fee from Glaxo Smith Kline. ML is supported by the Alexandre Suerman Stipend of the University Medical Center Utrecht.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36446465</ArticleId><ArticleId IdType="pmc">PMC9709810</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-065142</ArticleId><ArticleId IdType="pii">bmjopen-2022-065142</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus World Health Organization; 2021.</Citation></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021;27:1607&#x2013;13. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021;398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021;27:1507&#x2013;13. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv 2021. doi:10.1101/2021.01.27.21250617. [Epub ahead of print: 30 Jan 2021].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al. . Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 2022;101:93&#x2013;135. 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S, Philip KEJ, Williams P, et al. . Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Resp Res 2021;8:e001075. 10.1136/bmjresp-2021-001075</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001075</ArticleId><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JH, Womack KN, Tenforde MW, et al. . Associations between persistent symptoms after mild COVID&#x2010;19 and long&#x2010;term health status, quality of life, and psychological distress. Influenza Other Respi Viruses 2022;16:680&#x2013;9. 10.1111/irv.12980</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12980</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Kelly B, Vidal L, Avramovic G, et al. . Assessing the impact of COVID-19 at 1-year using the SF-12 questionnaire: data from the anticipate longitudinal cohort study. Int J Infect Dis 2022;118:236&#x2013;43. 10.1016/j.ijid.2022.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.03.013</ArticleId><ArticleId IdType="pmc">PMC8920113</ArticleId><ArticleId IdType="pubmed">35301101</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, et al. . Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28:583&#x2013;90. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection. JAMA Network Open 2021;4:e2128568&#x2013;e68. 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrosa AL, Bitencourt L, Fr&#xf3;es ACF, et al. . Emotional, behavioral, and psychological impact of the COVID-19 pandemic. Front Psychol 2020;11:566212&#x2013;12. 10.3389/fpsyg.2020.566212</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.566212</ArticleId><ArticleId IdType="pmc">PMC7561666</ArticleId><ArticleId IdType="pubmed">33117234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicola M, Alsafi Z, Sohrabi C, et al. . The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 2020;78:185&#x2013;93. 10.1016/j.ijsu.2020.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.04.018</ArticleId><ArticleId IdType="pmc">PMC7162753</ArticleId><ArticleId IdType="pubmed">32305533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, van Willigen HDG, Dijkstra M, et al. . Evolution of COVID-19 symptoms during the first 12 months after illness onset. Clin Infect Dis 2021. 10.1093/cid/ciab759</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, et al. . Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovanoski N, Chen X, Becker U, et al. . Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database. BMJ Open 2021;11:e056284. 10.1136/bmjopen-2021-056284</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-056284</ArticleId><ArticleId IdType="pmc">PMC9065767</ArticleId><ArticleId IdType="pubmed">34893488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect 2021. 10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC who clinical characterisation protocol. Lancet Reg Health Eur 2021;8:100186. 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, et al. . Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med 2012;40:502&#x2013;9. 10.1097/CCM.0b013e318232da75</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232da75</ArticleId><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiertz CMH, Vints WAJ, Maas GJCM, et al. . COVID-19: patient characteristics in the first phase of Postintensive care rehabilitation. Arch Rehabil Res Clin Transl 2021;3:100108. 10.1016/j.arrct.2021.100108</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arrct.2021.100108</ArticleId><ArticleId IdType="pmc">PMC7859717</ArticleId><ArticleId IdType="pubmed">33558860</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems LH, Nagy M, ten Cate H, et al. . Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3&#xa0;months after COVID-19. Thromb Res 2022;209:106&#x2013;14. 10.1016/j.thromres.2021.11.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.027</ArticleId><ArticleId IdType="pmc">PMC8642246</ArticleId><ArticleId IdType="pubmed">34922160</ArticleId></ArticleIdList></Reference><Reference><Citation>Linschoten M, Asselbergs FW. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic. Eur Heart J 2020;41:1795&#x2013;6. 10.1093/eurheartj/ehaa280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa280</ArticleId><ArticleId IdType="pmc">PMC7184392</ArticleId><ArticleId IdType="pubmed">32267494</ArticleId></ArticleIdList></Reference><Reference><Citation>Linschoten M, Uijl A, Schut A, et al. . Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. Eur Heart J 2022;43:1104&#x2013;20. 10.1093/eurheartj/ehab656</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab656</ArticleId><ArticleId IdType="pubmed">34734634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruip MJHA, Cannegieter SC, ten Cate H, et al. . Caging the dragon: research approach to COVID&#x2010;19&#x2013;related thrombosis. Res Pract Thromb Haemost 2021;5:278&#x2013;90. 10.1002/rth2.12470</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12470</ArticleId><ArticleId IdType="pmc">PMC7938618</ArticleId><ArticleId IdType="pubmed">33733026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tas J, van Gassel RJJ, Heines SJH, et al. . Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht intensive care COVID cohort (MaastrICCht). BMJ Open 2020;10:e040175. 10.1136/bmjopen-2020-040175</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040175</ArticleId><ArticleId IdType="pmc">PMC7526030</ArticleId><ArticleId IdType="pubmed">32994259</ArticleId></ArticleIdList></Reference><Reference><Citation>Long D, Haagsma JA, Janssen MF, et al. . Health-related quality of life and mental well-being of healthy and diseased persons in 8 countries: does stringency of government response against early COVID-19 matter? SSM Popul Health 2021;15:100913. 10.1016/j.ssmph.2021.100913</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ssmph.2021.100913</ArticleId><ArticleId IdType="pmc">PMC8426285</ArticleId><ArticleId IdType="pubmed">34522763</ArticleId></ArticleIdList></Reference><Reference><Citation>Leijte WT, Wagemaker NM, van Kraaij TD, et al. . Sterfte en heropname Na ziekenhuisopname Met covid-19. Ned Tijdschr Geneeskd 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33332036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg IJsbrandJ, et al. . The fair guiding principles for scientific data management and stewardship. Sci Data 2016;3:160018. 10.1038/sdata.2016.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, White IR, Carlin JB, et al. . Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393. 10.1136/bmj.b2393</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2393</ArticleId><ArticleId IdType="pmc">PMC2714692</ArticleId><ArticleId IdType="pubmed">19564179</ArticleId></ArticleIdList></Reference><Reference><Citation>Castela Forte J, Perner A, van der Horst ICC. The use of clustering algorithms in critical care research to unravel patient heterogeneity. Intensive Care Med 2019;45:1025&#x2013;8. 10.1007/s00134-019-05631-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05631-z</ArticleId><ArticleId IdType="pubmed">31062051</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, et al. . Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020;6:m1328. 10.1136/bmj.m1328</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Snell KIE, Ensor J, et al. . Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med 2019;38:1276&#x2013;96. 10.1002/sim.7992</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7992</ArticleId><ArticleId IdType="pmc">PMC6519266</ArticleId><ArticleId IdType="pubmed">30357870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et al. . One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res 2022;145:118&#x2013;24. 10.1016/j.jpsychires.2021.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8607816</ArticleId><ArticleId IdType="pubmed">34894521</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, Royal College of General Practitioners . COVID-19 rapid guideline: managing the long-term effects of COVID-19; 2021.</Citation></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med 2021;27:1129&#x2013;30. 10.1038/s41591-021-01402-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01402-w</ArticleId><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>May T, Aughterson H, Fancourt D, et al. . &#x2018;Stressed, uncomfortable, vulnerable, neglected&#x2019;: a qualitative study of the psychological and social impact of the COVID-19 pandemic on UK frontline keyworkers. BMJ Open 2021;11:e050945. 10.1136/bmjopen-2021-050945</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-050945</ArticleId><ArticleId IdType="pmc">PMC8593269</ArticleId><ArticleId IdType="pubmed">34772752</ArticleId></ArticleIdList></Reference><Reference><Citation>Epifanio MS, Andrei F, Mancini G, et al. . The impact of COVID-19 pandemic and Lockdown measures on quality of life among Italian general population. JCM 2021;10:289. 10.3390/jcm10020289</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10020289</ArticleId><ArticleId IdType="pmc">PMC7830623</ArticleId><ArticleId IdType="pubmed">33466778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>